Clinical trials should be accessible to the population suffering from the illness. However, with a limited number of research sites conducting the majority of the world’s clinical trials, how can trials really be accessible to all patients?
Clinical trial diversity is a multi-layered problem, and one that fundamentally must start with physicians. More principal investigators on more studies will open clinical trials to populations that otherwise could be left behind. How do we make clinical trials simpler for clinical staff so they want to participate? And therefore we increase accessibility to a broader number of patients?
The webinar will include a roundtable discussion moderated by Cayce Drobek, Teckro Director of Clinical Operations with:
During this session, Ken Getz will unveil new industry research on perceptions of clinical trial protocols.
If you miss the live session, the recording will be made available to all registrants.
The session includes a panel of speakers:
Kenneth A. Getz, MBA, Deputy Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Cassandra Smith, MBA, Director, Diversity and Inclusion in Clinical Trials Lead, Janssen R&D
Brendan Buckley, Teckro Chief Medical Officer
Cayce Drobek, Teckro Director of Clinical Operations